NMRA

NMRA

USD

Neumora Therapeutics Inc. Common Stock

$2.878+0.318 (12.422%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.560

最高价

$2.920

最低价

$2.550

成交量

1.60M

公司基本面

市值

480.9M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

1.36M

交易所

NMS

货币

USD

52周价格范围

最低价 $0.611当前价 $2.878最高价 $14.09

相关新闻

GlobeNewswire

Neumora Therapeutics to Participate in Upcoming Conferences in November

WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NASDAQ:NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel

查看更多
Neumora Therapeutics to Participate in Upcoming Conferences in November
Analyst Upgrades

Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8

Needham analyst Ami Fadia maintains Neumora Therapeutics with a Buy and raises the price target from $6 to $8.

查看更多
Needham Maintains Buy on Neumora Therapeutics, Raises Price Target to $8
Analyst Upgrades

Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target

Guggenheim analyst Yatin Suneja upgrades Neumora Therapeutics from Neutral to Buy and announces $14 price target.

查看更多
Guggenheim Upgrades Neumora Therapeutics to Buy, Announces $14 Price Target
GlobeNewswire

Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model

NMRA-215 demonstrated class-leading weight loss of up to 19% as a monotherapy with semaglutide-like induction NMRA-215 demonstrated best-in-class weight loss of up to 26% in combination with semaglutide Class-leading

查看更多
Neumora Therapeutics Announces Class-Leading Weight Loss Demonstrated with NMRA-215 in Preclinical Diet-Induced Obesity Model